Sunesis Pharmaceuticals (SNSS) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
Research and development: 6.61M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 6.61M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q4 EPS of ($0.19), in-line with the analyst estimate of ($0.19).
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- zSpace, Inc. (ZSPC) Reports Q2 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
